Doppl SA develops and engineers industry-standard organoids for disease modeling and personalized medicine. The company provides services including compound profiling (toxicity screening) using human gastrointestinal organoids, epithelial fluid transport assays, and customized organoid model development for preclinical drug development.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Model development of custom organoid lines that model tissues or diseases; support for research and development projects as well as preclinical drug development.
Compound Profiling
Toxicity screening using established models of healthy human gastrointestinal organoids for drug assessment and preclinical research.
Epithelial Fluid Transport
Screening of epithelial fluid transport using established models of healthy human gastrointestinal organoids.